Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells

Radiotherapy and Oncology

Volumn 76, Issue 2, 2005, Pages 200-205

  Said, Harun M ^a   Katzer, Astrid ^a   Flentje, Michael ^a   Vordermark, Dirk ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

GAPDH expression; Osteopontin; Oxygen; Radiotherapy; Tumor hypoxia

Indexed keywords

CELL PROTEIN; OSTEOPONTIN;

CANCER CELL CULTURE; COLORECTAL CARCINOMA; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG CANCER; NORTHERN BLOTTING; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; REOXYGENATION; WESTERN BLOTTING;

CELL ADHESION; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; NEOPLASM PROTEINS; OSTEOPONTIN; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 28444471148     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.06.023     Document Type: Conference Paper

References (24)

1. R. Agnihotri, H.C. Crawford, and H. Haro Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin) J Biol Chem 276 2001 28261 28267
2. L. Bentzen, S. Keiding, and M. Nordsmark Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours Radiother Oncol 67 2003 339 344
3. L.F. Brown, B. Berse, and L. Van de Water Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces Mol Biol Cell 3 1992 1169 1180
4. J. Bussink, J.H. Kaanders, and A.J. van der Kogel Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother Oncol 67 2003 3 15
5. P. Chomczynski, and V. Sacchi Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
6. K.K. Graven, R.F. Troxler, and H. Kornfeld Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia J Biol Chem 269 1994 24446 24453
7. D.J. Hampel, C. Sansome, and V.I. Romanov Osteopontin traffic in hypoxic renal epithelial cells Nephron Exp Nephrol 94 2003 e66 e76
8. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
9. P.J. Hoskin, A. Sibtain, and F.M. Daley The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma Radiother Oncol 72 2004 159 168
10. Q.T. Le, P.D. Sutphin, and S. Raychaudhuri Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin Cancer Res 9 2003 59 67
11. D. Leali, P. Dell'Era, and H. Stabile Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis J Immunol 171 2003 1085 1093
12. S. Lukacova, A. Khalil, and J. Overgaard Serum osteopontin as a marker for hypoxia in tumours [abstract] Mol Radiat Oncol Biol 5 2004 75
13. B.J. Moeller, Y. Cao, and C.Y. Li Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell 5 2004 429 441
14. M. Nordsmark, J. Loncaster, and C. Aquino-Parsons Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas Radiother Oncol 67 2003 35 44
15. M. Nordsmark, J. Eriksen, and M. Horsman Clinical significance of tumour hypoxia [abstract] Eur J Cancer Suppl 2 2004 75 76
16. S.R. Rittling, and A.F. Chambers Role of osteopontin in tumor progression Br J Cancer 90 2004 1877 1881
17. H.W. Salmon, and D.W. Siemann Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors Radiother Oncol 73 2004 359 366
18. G.N. Thalmann, R.A. Sikes, and R.E. Devoll Osteopontin: possible role in prostate cancer progression Clin Cancer Res 5 1999 2271 2277
19. K. Tokunaga, Y. Nakamura, and K. Sakata Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers Cancer Res 47 1987 5616 5619
20. A.B. Tuck, F.P. O'Malley, and H. Singhal Osteopontin expression in a group of lymph node negative breast cancer patients Int J Cancer 79 1998 502 508
21. D. Vordermark, and J.M. Brown Endogenous markers of tumor hypoxia: predictors of clinical radiation resistance? Strahlenther Onkol 179 2003 801 811
22. D. Vordermark, A. Katzer, and K. Baier Cell-type specific association of hypoxia-inducible factor-1α (HIF-1α) protein accumulation and radiobiologic tumor hypoxia Int J Radiat Oncol Biol Phys 58 2004 1242 1250
23. G.F. Weber The metastasis gene osteopontin: a candidate target for cancer therapy Biochim Biophys Acta 1552 2001 61 85
24. H. Zhong, and J.W. Simons Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia Biochem Biophys Res Commun 259 1999 523 526